- Report
- July 2024
- 105 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- November 2023
- 114 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2023
- 146 Pages
Global
From €3343EUR$3,528USD£2,821GBP
€3933EUR$4,150USD£3,319GBP
- Report
- October 2024
- 70 Pages
Global
From €900EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Japan
From €900EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United States
From €900EUR$950USD£760GBP
- Report
- December 2023
- 132 Pages
Global
From €900EUR$950USD£760GBP
- Report
- August 2022
- 329 Pages
Global
From €3497EUR$3,690USD£2,951GBP
The Antinuclear Antibodies Test (ANA) is a diagnostic test used to detect the presence of antinuclear antibodies (ANA) in the blood. ANA are autoantibodies that are produced by the body's immune system and can be used to diagnose autoimmune diseases such as systemic lupus erythematosus (SLE). The ANA test is used to detect the presence of ANA in the blood, which can help diagnose autoimmune diseases and other conditions. The test is also used to monitor the progress of autoimmune diseases and to determine the effectiveness of treatments.
The ANA test market is a growing segment of the diagnostics industry, with a wide range of products available from a variety of companies. Companies offering ANA tests include Abbott, Bio-Rad, Siemens, Roche, and Thermo Fisher Scientific. Show Less Read more